13F filer · CIK 2050194
Spruce Street Capital LP
NEW YORK, NY · filing since Q4 2025 · last filing Aug 13, 2026
Reported value
$509.7M
+$93.7M vs prior
Positions
30
New / sold out
5 / 3
Added / reduced
8 / 1
Turnover
9.8%
buys $62.6M · sells $45.3M
Top-10 weight
70.2%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | INFLARX NV | +5,352,198 | – | +$12.0M |
| Added | ALKERMES PLC | +225,884 | +71.0% | +$11.8M |
| Added | KINIKSA PHARMACEUTICALS INTL | +157,007 | +20.6% | +$10.0M |
| New | RESEARCH ALLIANCE CORP III | +500,000 | – | +$5.3M |
| New | ZAI LAB LTD | +279,110 | – | +$5.3M |
| New | ACHIEVE LIFE SCIENCE INC | +736,637 | – | +$4.8M |
| Added | PERSPECTIVE THERAPEUTICS INC | +1,066,824 | +40.6% | +$3.6M |
| Added | VAXCYTE INC | +60,338 | +24.6% | +$3.5M |
| Added | ENANTA PHARMACEUTICALS INC | +156,133 | +16.7% | +$2.3M |
| New | JATT II ACQUISITION CORP | +160,000 | – | +$1.8M |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | CENTESSA PHARMACEUTICALS | -489,849 | -100.0% | $-19.5M |
| Sold out | KALVISTA PHARMACEUTICALS | -897,681 | -100.0% | $-18.1M |
| Sold out | MAZE THERAPEUTICS INC | -200,000 | -100.0% | $-6.0M |
| Reduced | DIANTHUS THERAPEUTICS INC | -18,458 | -4.9% | $-1.8M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | KINIKSA PHARMACEUTICALS INTLORD SHS CL A | 918,070 | $58.7M | 11.52% |
| 2 | RELAY THERAPEUTICS INCCOM | 2,984,125 | $55.8M | 10.95% |
| 3 | LB PHARMACEUTICALS INCCOM SHS | 1,376,159 | $44.7M | 8.76% |
| 4 | RELMADA THERAPEUTICS INCCOM | 6,391,328 | $44.2M | 8.68% |
| 5 | ALTO NEUROSCIENCE INCCOM SHS | 1,353,047 | $35.7M | 7.01% |
| 6 | DIANTHUS THERAPEUTICS INCCOM | 354,816 | $34.6M | 6.79% |
| 7 | ALKERMES PLCSHS | 543,876 | $28.5M | 5.59% |
| 8 | SAVARA INCCOM | 3,452,576 | $21.3M | 4.17% |
| 9 | VAXCYTE INCCOM | 306,047 | $17.8M | 3.49% |
| 10 | ENLIVEN THERAPEUTICS INCCOM | 329,006 | $16.7M | 3.28% |
20 more rows. Subscribe for $29/month to see every row, download the data and use the API.